Soleus Capital Management’s STAAR Surgical STAA Stock Holding History

Soleus Capital Management’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-20,000	Closed	-$374K	–	108
2026 Q1	$374K	Sell	20,000 -5,000	-20%	-$95.4K	0.02%	86
2025 Q4	$577K	Sell	25,000 -475,000	-95%	-$12.2M	0.02%	87
2025 Q3	$13.4M	Sell	500,000 -2,484,733	-83%	-$59.2M	0.68%	38
2025 Q2	$50.1M	Buy	2,984,733 +421,840	+16%	+$7.44M	3.32%	8
2025 Q1	$45.2M	Buy	+2,562,893	New	+$51.4M	3.25%	9
2023 Q1	–	Sell	-110,200	Closed	-$5.35M	–	96
2022 Q4	$5.35M	Buy	+110,200	New	+$6.91M	0.77%	38
2022 Q3	–	Sell	-75,094	Closed	-$5.33M	–	88
2022 Q2	$5.33M	Buy	+75,094	New	+$4.84M	0.83%	38
2021 Q2	–	Sell	-16,700	Closed	-$1.76M	–	76
2021 Q1	$1.76M	Buy	16,700 +13,400	+406%	+$1.34M	0.32%	53
2020 Q4	$261K	Sell	3,300 -12,046	-78%	-$881K	0.03%	65
2020 Q3	$868K	Sell	15,346 -5,082	-25%	-$274K	0.46%	46
2020 Q2	$1.26M	Buy	20,428 +12,630	+162%	+$516K	0.72%	35
2020 Q1	$252K	Sell	7,798 -28,142	-78%	-$948K	0.29%	39
2019 Q4	$1.26M	Buy	+35,940	New	+$1.19M	1.22%	27

Other funds holding STAA

Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return

Yunqi Capital Hong Kong $125M AUM 13.99% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AIM

Anatole Investment Management Central, Hong Kong $590M AUM 751.98% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Soleus Capital Management's STAA Position: Q2 2026 in Review

Soleus Capital Management sold out of STAAR Surgical (STAA) in Q2 2026, closing a stake of 20,000 shares — an estimated $374K sold.

Soleus Capital Management first reported a position in STAA in Q4 2019 and held it in 13 quarters. The position peaked at $50.1M in Q2 2025. 200 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

Soleus Capital Management reported no remaining STAAR Surgical position as of Q2 2026 after selling out during the quarter.
Soleus Capital Management sold 20,000 STAAR Surgical shares in Q2 2026, an estimated $374K.
Soleus Capital Management first reported a position in STAAR Surgical in Q4 2019 and held it in 13 quarters.
Soleus Capital Management's STAAR Surgical position peaked at $50.1M in Q2 2025.
200 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.